{"id":19116,"date":"2025-11-19T09:30:00","date_gmt":"2025-11-19T14:30:00","guid":{"rendered":"https:\/\/innovativemedicines.ca\/newsroom\/all-news\/"},"modified":"2025-11-19T09:30:05","modified_gmt":"2025-11-19T14:30:05","slug":"medicaments-novateurs-canada-annonce-la-nomination-de-gaby-bourbara-a-la-presidence-de-son-conseil-dadministration","status":"publish","type":"news","link":"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/medicaments-novateurs-canada-annonce-la-nomination-de-gaby-bourbara-a-la-presidence-de-son-conseil-dadministration\/","title":{"rendered":"M\u00e9dicaments novateurs Canada annonce la nomination de Gaby Bourbara \u00e0 la pr\u00e9sidence de son conseil d\u2019administration"},"content":{"rendered":"\n<p><strong>Ottawa, le 19&nbsp;novembre&nbsp;2025.&nbsp;\u2013<\/strong> <a href=\"https:\/\/innovativemedicines.ca\/fr\/\">M\u00e9dicaments novateurs Canada (MNC)<\/a> est heureuse d\u2019annoncer la nomination de Gaby Bourbara, pr\u00e9sident d\u2019<a href=\"https:\/\/www.astrazeneca.ca\/fr\">AstraZeneca Canada<\/a>, \u00e0 la pr\u00e9sidence de son conseil d\u2019administration.<\/p>\n\n\n\n<p>Avec plus de vingt ans d\u2019exp\u00e9rience en mati\u00e8re de leadership dans l\u2019industrie biopharmaceutique canadienne et mondiale, M.&nbsp;Bourbara est connu pour son approche collaborative et sa conviction que la science a le pouvoir de transformer des vies.<\/p>\n\n\n\n<p>\u00ab&nbsp;M.&nbsp;Bourbara poss\u00e8de une exp\u00e9rience approfondie, des relations de confiance et un engagement in\u00e9branlable envers la collaboration&nbsp;\u00bb, a d\u00e9clar\u00e9 Bettina Hamelin, pr\u00e9sidente et cheffe de la direction de MNC. \u00ab&nbsp;Son leadership aidera l\u2019association et ses membres \u00e0 continuer \u00e0 r\u00e9aliser des progr\u00e8s importants pour les patients et \u00e0 renforcer la sant\u00e9 et l\u2019avenir \u00e9conomique du Canada.&nbsp;\u00bb<\/p>\n\n\n\n<p>En tant que pr\u00e9sident du conseil, M.&nbsp;Bourbara guidera les travaux de MNC visant \u00e0 acc\u00e9l\u00e9rer l\u2019acc\u00e8s des patients aux m\u00e9dicaments et vaccins novateurs et \u00e0 renforcer le secteur des sciences de la vie en tant que moteur essentiel de l\u2019\u00e9conomie canadienne.<\/p>\n\n\n\n<p>\u00ab&nbsp;Je suis honor\u00e9 d\u2019assumer ce r\u00f4le \u00e0 un moment aussi crucial pour notre industrie&nbsp;\u00bb, a d\u00e9clar\u00e9 Gaby Bourbara, pr\u00e9sident du conseil d\u2019administration de MNC. \u00ab&nbsp;Le Canada dispose d\u2019un bassin exceptionnel de chercheurs et de talents de renomm\u00e9e mondiale. Forte de ces atouts, notre industrie joue un r\u00f4le essentiel dans la sant\u00e9 des Canadiens et de l\u2019\u00e9conomie canadienne. Nous devons acc\u00e9l\u00e9rer les partenariats entre le gouvernement, les cliniciens et les communaut\u00e9s de patient afin de continuer \u00e0 offrir plus rapidement de nouveaux traitements aux patients et de cr\u00e9er un environnement plus favorable \u00e0 la recherche et \u00e0 l\u2019investissement en tant que leader mondial dans le domaine des sciences de la vie.&nbsp;\u00bb<\/p>\n\n\n\n<p>M.&nbsp;Bourbara succ\u00e8de \u00e0 Brigitte Nolet, pr\u00e9sidente-directrice g\u00e9n\u00e9rale de Roche Canada Pharma, qui a occup\u00e9 le poste de pr\u00e9sidente du conseil de 2023 \u00e0 2025.<\/p>\n\n\n\n<p><strong>\u00c0 propos de M\u00e9dicaments novateurs Canada<\/strong><\/p>\n\n\n\n<p>M\u00e9dicaments novateurs Canada (MNC) est l\u2019association nationale qui repr\u00e9sente l\u2019industrie pharmaceutique novatrice canadienne. MNC plaide en faveur de politiques qui permettent la d\u00e9couverte, le d\u00e9veloppement et la distribution de m\u00e9dicaments et vaccins novateurs pour am\u00e9liorer la vie de tous les Canadiens. Elle d\u00e9fend aussi l\u2019engagement de ses membres d\u2019\u00eatre un partenaire de confiance du syst\u00e8me de sant\u00e9 canadien. Ses membres investissent pr\u00e8s de 3,2&nbsp;milliards de dollars par an en recherche et d\u00e9veloppement. De cette fa\u00e7on, MNC alimente l\u2019\u00e9conomie fond\u00e9e sur la connaissance du pays tout en contribuant \u00e0 hauteur de 18,4&nbsp;milliards de dollars \u00e0 l\u2019\u00e9conomie nationale annuellement. Tous ses membres suivent le Code d\u2019\u00e9thique de MNC, ils travaillent donc de mani\u00e8re hautement \u00e9thique avec les gouvernements, les payeurs priv\u00e9s, les professionnels de la sant\u00e9 et les parties prenantes.<\/p>\n\n\n\n<p>Pour de plus amples informations, veuillez \u00e9crire \u00e0 <a><\/a><a href=\"mailto:media@imc-mnc.ca\">media@imc-mnc.ca<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Ottawa, le 19&nbsp;novembre&nbsp;2025.&nbsp;\u2013 M\u00e9dicaments novateurs Canada (MNC) est heureuse d\u2019annoncer la nomination de Gaby Bourbara, pr\u00e9sident d\u2019AstraZeneca Canada, \u00e0 la [&hellip;]<\/p>\n","protected":false},"featured_media":0,"template":"","topic":[],"team-member-id":[],"news-category":[176],"news-tag":[],"class_list":["post-19116","news","type-news","status-publish","hentry","news-category-communique"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>M\u00e9dicaments novateurs Canada annonce la nomination de Gaby Bourbara \u00e0 la pr\u00e9sidence de son conseil d\u2019administration - Innovative Medicines Canada<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/medicaments-novateurs-canada-annonce-la-nomination-de-gaby-bourbara-a-la-presidence-de-son-conseil-dadministration\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"M\u00e9dicaments novateurs Canada annonce la nomination de Gaby Bourbara \u00e0 la pr\u00e9sidence de son conseil d\u2019administration - Innovative Medicines Canada\" \/>\n<meta property=\"og:description\" content=\"Ottawa, le 19&nbsp;novembre&nbsp;2025.&nbsp;\u2013 M\u00e9dicaments novateurs Canada (MNC) est heureuse d\u2019annoncer la nomination de Gaby Bourbara, pr\u00e9sident d\u2019AstraZeneca Canada, \u00e0 la [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/medicaments-novateurs-canada-annonce-la-nomination-de-gaby-bourbara-a-la-presidence-de-son-conseil-dadministration\/\" \/>\n<meta property=\"og:site_name\" content=\"Innovative Medicines Canada\" \/>\n<meta property=\"article:modified_time\" content=\"2025-11-19T14:30:05+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/medicaments-novateurs-canada-annonce-la-nomination-de-gaby-bourbara-a-la-presidence-de-son-conseil-dadministration\/\",\"url\":\"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/medicaments-novateurs-canada-annonce-la-nomination-de-gaby-bourbara-a-la-presidence-de-son-conseil-dadministration\/\",\"name\":\"M\u00e9dicaments novateurs Canada annonce la nomination de Gaby Bourbara \u00e0 la pr\u00e9sidence de son conseil d\u2019administration - Innovative Medicines Canada\",\"isPartOf\":{\"@id\":\"https:\/\/innovativemedicines.ca\/fr\/#website\"},\"datePublished\":\"2025-11-19T14:30:00+00:00\",\"dateModified\":\"2025-11-19T14:30:05+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/medicaments-novateurs-canada-annonce-la-nomination-de-gaby-bourbara-a-la-presidence-de-son-conseil-dadministration\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/medicaments-novateurs-canada-annonce-la-nomination-de-gaby-bourbara-a-la-presidence-de-son-conseil-dadministration\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/medicaments-novateurs-canada-annonce-la-nomination-de-gaby-bourbara-a-la-presidence-de-son-conseil-dadministration\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/innovativemedicines.ca\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Newsroom\",\"item\":\"https:\/\/innovativemedicines.ca\/fr\/newsroom\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Newsroom\",\"item\":\"https:\/\/innovativemedicines.ca\/fr\/newsroom\/all-news\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"M\u00e9dicaments novateurs Canada annonce la nomination de Gaby Bourbara \u00e0 la pr\u00e9sidence de son conseil d\u2019administration\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/innovativemedicines.ca\/fr\/#website\",\"url\":\"https:\/\/innovativemedicines.ca\/fr\/\",\"name\":\"Innovative Medicines Canada\",\"description\":\"Transforming Canadians\u2019 lives\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/innovativemedicines.ca\/fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"M\u00e9dicaments novateurs Canada annonce la nomination de Gaby Bourbara \u00e0 la pr\u00e9sidence de son conseil d\u2019administration - Innovative Medicines Canada","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/medicaments-novateurs-canada-annonce-la-nomination-de-gaby-bourbara-a-la-presidence-de-son-conseil-dadministration\/","og_locale":"fr_FR","og_type":"article","og_title":"M\u00e9dicaments novateurs Canada annonce la nomination de Gaby Bourbara \u00e0 la pr\u00e9sidence de son conseil d\u2019administration - Innovative Medicines Canada","og_description":"Ottawa, le 19&nbsp;novembre&nbsp;2025.&nbsp;\u2013 M\u00e9dicaments novateurs Canada (MNC) est heureuse d\u2019annoncer la nomination de Gaby Bourbara, pr\u00e9sident d\u2019AstraZeneca Canada, \u00e0 la [&hellip;]","og_url":"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/medicaments-novateurs-canada-annonce-la-nomination-de-gaby-bourbara-a-la-presidence-de-son-conseil-dadministration\/","og_site_name":"Innovative Medicines Canada","article_modified_time":"2025-11-19T14:30:05+00:00","twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/medicaments-novateurs-canada-annonce-la-nomination-de-gaby-bourbara-a-la-presidence-de-son-conseil-dadministration\/","url":"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/medicaments-novateurs-canada-annonce-la-nomination-de-gaby-bourbara-a-la-presidence-de-son-conseil-dadministration\/","name":"M\u00e9dicaments novateurs Canada annonce la nomination de Gaby Bourbara \u00e0 la pr\u00e9sidence de son conseil d\u2019administration - Innovative Medicines Canada","isPartOf":{"@id":"https:\/\/innovativemedicines.ca\/fr\/#website"},"datePublished":"2025-11-19T14:30:00+00:00","dateModified":"2025-11-19T14:30:05+00:00","breadcrumb":{"@id":"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/medicaments-novateurs-canada-annonce-la-nomination-de-gaby-bourbara-a-la-presidence-de-son-conseil-dadministration\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/medicaments-novateurs-canada-annonce-la-nomination-de-gaby-bourbara-a-la-presidence-de-son-conseil-dadministration\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/medicaments-novateurs-canada-annonce-la-nomination-de-gaby-bourbara-a-la-presidence-de-son-conseil-dadministration\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/innovativemedicines.ca\/fr\/"},{"@type":"ListItem","position":2,"name":"Newsroom","item":"https:\/\/innovativemedicines.ca\/fr\/newsroom\/"},{"@type":"ListItem","position":3,"name":"Newsroom","item":"https:\/\/innovativemedicines.ca\/fr\/newsroom\/all-news\/"},{"@type":"ListItem","position":4,"name":"M\u00e9dicaments novateurs Canada annonce la nomination de Gaby Bourbara \u00e0 la pr\u00e9sidence de son conseil d\u2019administration"}]},{"@type":"WebSite","@id":"https:\/\/innovativemedicines.ca\/fr\/#website","url":"https:\/\/innovativemedicines.ca\/fr\/","name":"Innovative Medicines Canada","description":"Transforming Canadians\u2019 lives","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/innovativemedicines.ca\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"}]}},"_links":{"self":[{"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/news\/19116","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/types\/news"}],"wp:attachment":[{"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/media?parent=19116"}],"wp:term":[{"taxonomy":"topic","embeddable":true,"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/topic?post=19116"},{"taxonomy":"team-member-id","embeddable":true,"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/team-member-id?post=19116"},{"taxonomy":"news-category","embeddable":true,"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/news-category?post=19116"},{"taxonomy":"news-tag","embeddable":true,"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/news-tag?post=19116"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}